Galena Biopharma To Present At The Rodman And Renshaw 14th Annual Investment Conference

LAKE OSWEGO, Ore., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and CEO, will present a corporate overview at the Rodman and Renshaw 14 th Annual Healthcare Conference. The presentation will take place on Monday, September 10, 2012 at 2:50 p.m. EDT at the Waldorf Astoria Hotel in New York, NY.

The presentation will be webcast and available on the Company's website at http://investors.galenabiopharma.com/events.cfm .

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com .

The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647
CONTACT: Madeline Hatton         Toll free: +1 (855) 855-GALE (4253), ext. 109         info@galenabiopharma.com                  or                  Remy Bernarda         IR Sense, LLC         +1 (415) 203-6386         remy@irsense.com

Galena Biopharma, Inc.

If you liked this article you might like

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

How to Dig Deep for Value in These Exuberant Markets

How to Dig Deep for Value in These Exuberant Markets

Value Investors Have to Go Deeper

Value Investors Have to Go Deeper

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments

How to Expertly Trade Monday's Most Active Stocks -- AMD, Newell Brands, Hasbro and More